Shingrix is a onetime vaccination, given in two doses a few months apart. The CDC recommends it starting at age 50 for most ...

Several previous studies have suggested that shingles vaccinations might reduce dementia risk, but most could not exclude the ...

Getting vaccinated against shingles may not only lower risk for the condition — it may offer some protection against dementia ...

While anyone who has had chicken pox still has the virus in their system, flare-ups in older adulthood are typically more ...

New research has linked the shingles vaccine to a reduced risk of dementia, but who is eligible for the jab and what are the ...

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Researchers at Stanford University found evidence that suggests the shingles vaccine lowers the risk of developing dementia. Evidence from the study suggested the vaccine cut the risk of developing ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Shingles are more common than people think but there is help in the form of a vaccination. SHINGRIX is an FDA-approved vaccine for the prevention of shingles in adults 50 years ...

Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia ...